Get the Stockscreener App
28.25
4.51%
1.22
After Hours:
28.25
Enovis Corp stock is traded at $28.25, with a volume of 827.68K.
It is up +4.51% in the last 24 hours and up +24.39% over the past month.
Enovis Corp is a medical technology manufacturer and distributor of medical devices used in reconstructive surgery, rehabilitation, pain management, and physical therapy. Its products support patient care from injury prevention through post-surgical or post-injury rehabilitation and treatment of degenerative conditions. The company's reportable segments include Prevention & Recovery and Reconstructive segments. The majority of revenueis derived from the Prevention & Recovery segment, which includes products that are used by orthopedic specialists, primary care physicians, physical therapists, chiropractors, athletic trainers and other healthcare professionals to treat patients with musculoskeletal conditions resulting from degenerative diseases, deformitiesand sports-related injuries.
See More
Previous Close:
$27.03
Open:
$27.47
24h Volume:
827.68K
Relative Volume:
0.72
Market Cap:
$1.63B
Revenue:
$2.28B
Net Income/Loss:
$-1.13B
P/E Ratio:
-1.4225
EPS:
-19.86
Net Cash Flow:
$35.92M
1W Performance:
+5.25%
1M Performance:
+24.39%
6M Performance:
+28.53%
1Y Performance:
+2.58%
1-Day Range:
$27.46
$28.30
1-Week Range:
$25.40
$28.30
52-Week Range:
$19.14
$34.28
Enovis Corp Stock (ENOV) Company Profile
Name
Enovis Corp
Sector
Industry
Phone
(302) 252-9160
Address
2711 CENTERVILLE ROAD, WILMINGTON
Compare ENOV vs ABT, SYK, MDT, BSX, EW
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
ENOV
Enovis Corp
|
28.25 | 1.56B | 2.28B | -1.13B | 35.92M | -19.86 |
ABT
Abbott Laboratories
|
104.49 | 179.51B | 46.59B | 5.41B | 7.38B | 3.0938 |
SYK
Stryker Corp
|
336.74 | 126.60B | 25.27B | 3.34B | 4.57B | 8.6334 |
MDT
Medtronic Plc
|
84.22 | 106.51B | 36.36B | 4.84B | 5.43B | 3.7261 |
BSX
Boston Scientific Corp
|
45.51 | 65.77B | 20.62B | 3.56B | 3.48B | 2.3847 |
EW
Edwards Lifesciences Corp
|
83.04 | 47.58B | 6.30B | 1.07B | 1.09B | 1.8406 |
Enovis Corp Stock (ENOV) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Apr-17-26 | Resumed | William Blair | Outperform |
| Jan-06-26 | Initiated | BTIG Research | Buy |
| Oct-03-24 | Initiated | JMP Securities | Mkt Outperform |
| Jun-13-24 | Initiated | JP Morgan | Neutral |
| Feb-13-24 | Initiated | Stephens | Overweight |
| Jan-22-24 | Initiated | UBS | Buy |
| Jan-03-24 | Initiated | William Blair | Outperform |
| Dec-15-23 | Reiterated | Needham | Buy |
| Oct-20-23 | Initiated | ROTH MKM | Buy |
| Jun-26-23 | Initiated | Needham | Buy |
| May-12-23 | Upgrade | Wells Fargo | Equal Weight → Overweight |
| Oct-12-22 | Initiated | Jefferies | Buy |
| Oct-11-22 | Initiated | Goldman | Buy |
| Sep-12-22 | Initiated | Canaccord Genuity | Buy |
| Sep-12-22 | Initiated | Evercore ISI | Outperform |
| Jun-28-22 | Initiated | Argus | Hold |
| Jun-27-22 | Resumed | Loop Capital | Buy |
| Jun-16-22 | Initiated | Wells Fargo | Equal Weight |
View All
Enovis Corp Stock (ENOV) Latest News
Enovis Corp (ENOV) Income Statement - TradingKey
Enovis Corp (ENOV) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Enovis Corp (ENOV) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Enovis Corp (ENOV) Balance Sheet - TradingKey
Enovis Corp (ENOV) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
ENOV|Enovis Corp|Price:27.030|Chg%:+0.990 - TradingKey
What's Driving the Recent Buzz Around Enovis (ENOV) Stock - Kavout | AI
Enovis Corporation (ENOV) Stock Forecasts - Yahoo Finance
Stocks making big moves this week: HCA Healthcare, UnitedHealth, CrowdStrike, RXO, and Enovis - MSN
Enovis Corporation (ENOV) Stock Analysis: A 51.74% Upside Potential with Strong Buy Ratings - DirectorsTalk Interviews
Enovis (ENOV) 43rd Annual J.P. Morgan Healthcare Conference 2025 Summary - Quartr
STAAR Surgical, Globus Medical, Integer Holdings, and Enovis stocks trade down, what you need to know - MSN
Is Enovis (ENOV) Undervalued On Its CT RevitL Launch Or Is That Priced In? - simplywall.st
Enovis Corp (ENOV) Shares Fall 3.6% -- What GF Score of 64 Tells Investors - GuruFocus
STAAR Surgical, Globus Medical, Integer Holdings, and Enovis Stocks Trade Down, What You Need To Know - Yahoo Finance
Is Enovis (ENOV) Using CT-RevitL to Quietly Redefine Its Veterinary Innovation Strategy? - simplywall.st
CFX5924786 Bond Profile — Key Metrics - TradingView
US194014AB2 Bond Profile — Key Metrics - TradingView
Enovis (ENOV) stock trades up, here is why - MSN
Enovis to host Q2 2026 results conference call on August 6 - scanx.trade
Enovis to Host Second Quarter 2026 Results Conference Call on August 6th - The Manila Times
Enovis Corporation to Host Second Quarter 2026 Investor Conference Call and Webcast on August 6 - Quiver Quantitative
Enovis will webcast its second-quarter results on Aug. 6 - Stock Titan
Enovis Corp (ENOV) Shares Surge 3.8% -- What GF Score of 60 Tells Investors - GuruFocus
Enovis Corporation (ENOV) Surges 4.36% as It Approaches Resistance LevelTurnaround Stocks - dars.gov.et
Enovis (ENOV) Receives a Buy from Jefferies - The Globe and Mail
Jefferies Initiates Enovis Corp(ENOV.US) With Buy Rating, Announces Target Price $40 - Moomoo
Enovis (ENOV) Stock Trades Up, Here Is Why - Yahoo Finance
Enovis Launches New Veterinary Laser Therapy System in the U.S. - Vet Candy
Enovis launches veterinary laser therapy system in U.S. - Investing.com
Enovis launches veterinary laser therapy system in U.S. By Investing.com - Investing.com Canada
Enovis™ Companion Animal Health Launches CT-RevitL™, the Next-Generation Laser Therapy System for Veterinary Care - The Manila Times
Enovis™ Companion Animal Health Launches CT-RevitL™, the - GlobeNewswire
CD&R Engages Former Enovis CEO as Operating Advisor - AOL.com
BMO Capital Maintains Enovis Corp(ENOV.US) With Buy Rating, Cuts Target Price to $29 - 富途牛牛
BMO Capital Initiates Enovis at Outperform With $29 Price Target - marketscreener.com
Does Enovis (ENOV) Leaving Russell Defensive Indexes Signal A Deeper Shift In Its Risk Profile? - simplywall.st
Enovis (ENOV) Coverage Started with Outperform Rating and $29 Ta - GuruFocus
American Century affiliates report 10.6% holdings in Enovis (ENOV) - Stock Titan
Enovis (ENOV) Following CMS Reversal, Why The Valuation Story Is Back In Focus - simplywall.st
Why Enovis (ENOV) Stock Is Trading Up Today - Yahoo Finance
Enovis shares jump after Medicare reverses reimbursement cuts By Investing.com - Investing.com Nigeria
Enovis shares jump after Medicare reverses reimbursement cuts - Investing.com
Evercore Maintains Enovis Corp(ENOV.US) With Buy Rating, Cuts Target Price to $32 - Moomoo
Enovis Corp Stock (ENOV) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.79%
4.39%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):